Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed May 6, 2016.
2.
LepistE-IZhangXHaoJ. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Kidney Int. 2014;86:350-357.
3.
EsterlyJSDarinKMGerzenshteinLOthmanFPostelnickMJScarsiKK.Clinical implications of antiretroviral drug interactions with warfarin: a case-control study. J Antimicrob Chemother. 2013;68:1360-1363.
4.
GoodBLGomesDCFulcoPP.An unexpected interaction between warfarin and cobicistat-boosted elvitegravir. AIDS. 2015;29:985-986.
5.
FinksSWTrujilloTCDobeshPP.Management of venous thromboembolism: recent advances in oral anticoagulation therapy. Ann Pharmacother. 2016;50:486-501.
6.
BrooksKMHadiganCGordonLA. Cobicistat increases the effects of dabigatran on thrombin time in healthy volunteers [poster 430]. Poster presented at: Conference on Retroviruses and Opportunistic Infections; February 22-25, 2016; Boston MA.
7.
EganGHugesCAAckmanML.Drug interactions between antiplatelet or novel oral anticoagulant medications and antiretroviral medications. Ann Pharmacother. 2014;48:734-740.
